{"transactions":[{"id":1418865,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:04.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":652,"price":0.56,"value":365.12,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":8128,"source":{"system":"sec-edgar","filing":"0000950170-24-102369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017024102369/ownership.xml","form_type":"4"}},{"id":1418864,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:30:04.000Z","date":"2024-08-28","kind":"purchase","planned":false,"acquired":true,"shares":749,"price":0.56,"value":419.44,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%).  The total amount invested in the LLC by these members was $130,750 as of the date of his filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":7476,"source":{"system":"sec-edgar","filing":"0000950170-24-102369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017024102369/ownership.xml","form_type":"4"}},{"id":1706826,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:43.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares beneficially owned by the Reporting Person include 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares beneficially owned by the Reporting Person include 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 18, 2023."}],"balance_after":63472,"source":{"system":"sec-edgar","filing":"0000950170-23-071162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023071162/ownership.xml","form_type":"4"}},{"id":1706825,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:43.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":739,"price":3.9351,"value":2908.0389,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":6727,"source":{"system":"sec-edgar","filing":"0000950170-23-071162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023071162/ownership.xml","form_type":"4"}},{"id":1706824,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-18T17:10:43.000Z","date":"2023-12-14","kind":"purchase","planned":false,"acquired":true,"shares":391,"price":3.6119,"value":1412.2529,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5988,"source":{"system":"sec-edgar","filing":"0000950170-23-071162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023071162/ownership.xml","form_type":"4"}},{"id":1712243,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:20.000Z","date":"2021-09-23","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares beneficially owned by the Reporting Person consist of 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 13, 2023."}],"balance_after":63472,"source":{"system":"sec-edgar","filing":"0000950170-23-070165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023070165/ownership.xml","form_type":"4"}},{"id":1712242,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:20.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":5.5713,"value":6056.0031,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":5597,"source":{"system":"sec-edgar","filing":"0000950170-23-070165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023070165/ownership.xml","form_type":"4"}},{"id":1712241,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:20.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":3.5016,"value":3806.2392,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":4510,"source":{"system":"sec-edgar","filing":"0000950170-23-070165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023070165/ownership.xml","form_type":"4"}},{"id":1712240,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T21:36:20.000Z","date":"2023-12-11","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":3.5271,"value":3833.9577,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":3423,"source":{"system":"sec-edgar","filing":"0000950170-23-070165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023070165/ownership.xml","form_type":"4"}},{"id":1717636,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-08","kind":"other","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The shares beneficially owned by the Reporting Person consist of 63,472 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of December 8, 2023."}],"balance_after":63472,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1717635,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-08","kind":"purchase","planned":false,"acquired":true,"shares":46,"price":3.15,"value":144.9,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":2336,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1717634,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-07","kind":"purchase","planned":false,"acquired":true,"shares":248,"price":3.0658,"value":760.3184,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.01 to $3.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":2290,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1717633,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-06","kind":"purchase","planned":false,"acquired":true,"shares":608,"price":3.0329,"value":1844.0032,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.99 to $3.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":2042,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1717632,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-05","kind":"purchase","planned":false,"acquired":true,"shares":347,"price":3.1048,"value":1077.3656,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":1434,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1717631,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T21:19:31.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":1087,"price":2.9984,"value":3259.2608,"ownership":{"direct":false,"nature":"By Carmell Insiders LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC (\"LLC\").  The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information).  The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%).  The total amount invested in the LLC by these members was $115,000 as of the date of this filing.  The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC."}],"balance_after":1087,"source":{"system":"sec-edgar","filing":"0000950170-23-069165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000095017023069165/ownership.xml","form_type":"4"}},{"id":1827686,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-18T20:32:31.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":32173,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 14, 2023, Alpha Healthcare Acquisition Corp. III (\"ALPA\") consummated a business combination (the \"Business Combination\") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (\"Merger Sub\") and Carmell Regen Med Corporation, a Delaware corporation (\"Legacy Carmell\"), ALPA changed its name to \"Carmell Therapeutics Corporation\" and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 32,173 shares of common stock of Legacy Carmell granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":32173,"derivative":{"exercise_price":2.11,"expiration_date":"2031-09-23","underlying":"Common Stock","underlying_shares":32173},"source":{"system":"sec-edgar","filing":"0001062993-23-015050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000106299323015050/form4.xml","form_type":"4"}},{"id":1827685,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-18T20:32:31.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":8509,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 14, 2023, Alpha Healthcare Acquisition Corp. III (\"ALPA\") consummated a business combination (the \"Business Combination\") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (\"Merger Sub\") and Carmell Regen Med Corporation, a Delaware corporation (\"Legacy Carmell\"), ALPA changed its name to \"Carmell Therapeutics Corporation\" and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 8,509 shares of common stock of Legacy Carmell (as defined below) granted on July 19, 2019, which vest as follows: (i) 25% vested on July 19, 2020, July 19, 2021 and July 19, 2022 and the remaining 25% will vest on July 19, 2023."}],"balance_after":8509,"derivative":{"exercise_price":2.27,"expiration_date":"2029-07-19","underlying":"Common Stock","underlying_shares":8509},"source":{"system":"sec-edgar","filing":"0001062993-23-015050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000106299323015050/form4.xml","form_type":"4"}},{"id":1827684,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-18T20:32:31.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":19910,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 14, 2023, Alpha Healthcare Acquisition Corp. III (\"ALPA\") consummated a business combination (the \"Business Combination\") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (\"Merger Sub\") and Carmell Regen Med Corporation, a Delaware corporation (\"Legacy Carmell\"), ALPA changed its name to \"Carmell Therapeutics Corporation\" and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options are fully vested and exercisable."}],"balance_after":19910,"derivative":{"exercise_price":1.79,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":19910},"source":{"system":"sec-edgar","filing":"0001062993-23-015050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000106299323015050/form4.xml","form_type":"4"}},{"id":1827683,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-18T20:32:31.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":16285,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 14, 2023, Alpha Healthcare Acquisition Corp. III (\"ALPA\") consummated a business combination (the \"Business Combination\") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (\"Merger Sub\") and Carmell Regen Med Corporation, a Delaware corporation (\"Legacy Carmell\"), ALPA changed its name to \"Carmell Therapeutics Corporation\" and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options are fully vested and exercisable."}],"balance_after":16285,"derivative":{"exercise_price":1.79,"expiration_date":"2026-07-16","underlying":"Common Stock","underlying_shares":16285},"source":{"system":"sec-edgar","filing":"0001062993-23-015050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1304554/000106299323015050/form4.xml","form_type":"4"}},{"id":2310038,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T21:11:35.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":5221,"price":2.87,"value":14984.27,"ownership":{"direct":true},"balance_after":58746,"source":{"system":"sec-edgar","filing":"0001161697-22-000151","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000151/form_4.xml","form_type":"4"}},{"id":2455542,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T21:17:07.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":5000,"price":3,"value":15000.0,"ownership":{"direct":true},"balance_after":53525,"source":{"system":"sec-edgar","filing":"0001161697-22-000004","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169722000004/form_4.xml","form_type":"4"}},{"id":2458990,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-27T21:55:44.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":5263,"price":2.85,"value":14999.55,"ownership":{"direct":true},"balance_after":48525,"source":{"system":"sec-edgar","filing":"0001161697-21-000592","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000592/form_4.xml","form_type":"4/A","original_submission_date":"2021-10-04"}},{"id":2553389,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:05:10.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":5263,"price":2.85,"value":14999.55,"ownership":{"direct":true},"balance_after":36525,"source":{"system":"sec-edgar","filing":"0001161697-21-000462","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000462/form_4.xml","form_type":"4"}},{"id":2642857,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-06T23:12:08.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":2263,"price":4.63,"value":10477.69,"ownership":{"direct":true},"balance_after":43262,"source":{"system":"sec-edgar","filing":"0001161697-21-000324","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000324/form_4.xml","form_type":"4"}},{"id":2762840,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T18:22:10.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":1775,"price":3.52,"value":6248.0,"ownership":{"direct":true},"balance_after":40999,"source":{"system":"sec-edgar","filing":"0001161697-21-000186","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000186/form_4.xml","form_type":"4"}},{"id":2926871,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T00:50:52.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":1246,"price":6.02,"value":7500.92,"ownership":{"direct":true},"balance_after":39224,"source":{"system":"sec-edgar","filing":"0001161697-21-000031","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169721000031/form_4.xml","form_type":"4"}},{"id":3017530,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T21:10:50.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":1039,"price":7.22,"value":7501.58,"ownership":{"direct":true},"balance_after":37978,"source":{"system":"sec-edgar","filing":"0001161697-20-000424","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000424/form_4.xml","form_type":"4"}},{"id":3095920,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T00:04:05.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":835,"price":8.98,"value":7498.3,"ownership":{"direct":true},"balance_after":36939,"source":{"system":"sec-edgar","filing":"0001161697-20-000281","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000281/form_4.xml","form_type":"4"}},{"id":3190042,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-01T20:46:01.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":1000,"price":7.5,"value":7500.0,"ownership":{"direct":true},"balance_after":36104,"source":{"system":"sec-edgar","filing":"0001161697-20-000134","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000134/form_4.xml","form_type":"4"}},{"id":3328320,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:49:10.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":1149,"price":6.53,"value":7502.97,"ownership":{"direct":true},"balance_after":35104,"source":{"system":"sec-edgar","filing":"0001161697-20-000004","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169720000004/form_4.xml","form_type":"4"}},{"id":3402054,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T21:37:38.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":1899,"price":3.95,"value":7501.05,"ownership":{"direct":true},"balance_after":33955,"source":{"system":"sec-edgar","filing":"0001161697-19-000410","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169719000410/form_4.xml","form_type":"4"}},{"id":3402053,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T21:37:38.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":4,"price":2.88,"value":11.52,"ownership":{"direct":true},"balance_after":32056,"source":{"system":"sec-edgar","filing":"0001161697-19-000410","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169719000410/form_4.xml","form_type":"4"}},{"id":3457696,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-23T21:00:25.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":2428,"price":2.88,"value":6992.64,"ownership":{"direct":true},"balance_after":32052,"source":{"system":"sec-edgar","filing":"0001161697-19-000313","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169719000313/form_4.xml","form_type":"4/A","original_submission_date":"2019-07-02"}},{"id":3473214,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T20:54:43.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":3148,"price":2.88,"value":9066.24,"ownership":{"direct":true},"balance_after":32772,"source":{"system":"sec-edgar","filing":"0001161697-19-000279","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169719000279/form_4.xml","form_type":"4"}},{"id":3570750,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T21:29:22.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":3906,"price":1.6,"value":6249.6,"ownership":{"direct":true},"balance_after":29624,"source":{"system":"sec-edgar","filing":"0001161697-19-000129","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169719000129/form_4.xml","form_type":"4"}},{"id":3715299,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T23:28:54.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":1894,"price":1.65,"value":3125.1,"ownership":{"direct":true},"balance_after":25718,"source":{"system":"sec-edgar","filing":"0001161697-19-000006","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169719000006/form_4.xml","form_type":"4"}},{"id":3803396,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-02T21:59:19.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":1894,"price":1.65,"value":3125.1,"ownership":{"direct":true},"balance_after":23824,"source":{"system":"sec-edgar","filing":"0001161697-18-000464","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169718000464/form_4.xml","form_type":"4"}},{"id":3877448,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T20:42:18.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":2264,"price":1.38,"value":3124.32,"ownership":{"direct":true},"balance_after":21930,"source":{"system":"sec-edgar","filing":"0001161697-18-000347","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169718000347/form_4.xml","form_type":"4"}},{"id":3977848,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T19:57:33.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":2404,"price":1.3,"value":3125.2,"ownership":{"direct":true},"balance_after":19666,"source":{"system":"sec-edgar","filing":"0001161697-18-000170","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169718000170/form_4.xml","form_type":"4"}},{"id":4118407,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-02T22:38:44.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":2500,"price":1.25,"value":3125.0,"ownership":{"direct":true},"balance_after":17262,"source":{"system":"sec-edgar","filing":"0001161697-18-000008","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169718000008/form_4.xml","form_type":"4"}},{"id":4198561,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T01:44:34.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":5896,"price":0.53,"value":3124.88,"ownership":{"direct":true},"balance_after":14762,"source":{"system":"sec-edgar","filing":"0001161697-17-000429","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000429/form_4.xml","form_type":"4"}},{"id":4266522,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T19:55:55.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":8866,"price":0.47,"value":4167.02,"ownership":{"direct":true},"balance_after":8866,"source":{"system":"sec-edgar","filing":"0001161697-17-000306","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000306/form_4.xml","form_type":"4"}},{"id":4298998,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T20:52:42.000Z","date":"2017-05-30","kind":"sale","acquired":false,"shares":7353,"price":0.4,"value":2941.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued to the Reporting Person in lieu of fees for service as a director of the Company pursuant to transactions exempt under Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001161697-17-000272","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000272/form_4.xml","form_type":"4"}},{"id":4302139,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T01:16:38.000Z","date":"2017-05-17","kind":"sale","acquired":false,"shares":23315,"price":0.4,"value":9326.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As a result of the incorrect number of shares reported on in the reporting person's Form 4 filed on October 27, 2016, the amount of securities beneficially owned following reported transactions were then also reported incorrectly on his Form 4's with transaction dates of March 2, 2017 and May 17, 2017."}],"balance_after":7353,"source":{"system":"sec-edgar","filing":"0001161697-17-000270","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000270/form_4.xml","form_type":"4/A","original_submission_date":"2016-10-27"}},{"id":4302138,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T01:16:38.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":7353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As a result of the incorrect number of shares reported on in the reporting person's Form 4 filed on October 27, 2016, the amount of securities beneficially owned following reported transactions were then also reported incorrectly on his Form 4's with transaction dates of March 2, 2017 and May 17, 2017."}],"balance_after":30177,"source":{"system":"sec-edgar","filing":"0001161697-17-000270","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000270/form_4.xml","form_type":"4/A","original_submission_date":"2016-10-27"}},{"id":4302137,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T01:16:38.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":6793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As a result of the incorrect number of shares reported on in the reporting person's Form 4 filed on October 27, 2016, the amount of securities beneficially owned following reported transactions were then also reported incorrectly on his Form 4's with transaction dates of March 2, 2017 and May 17, 2017."}],"balance_after":23315,"source":{"system":"sec-edgar","filing":"0001161697-17-000270","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000270/form_4.xml","form_type":"4/A","original_submission_date":"2016-10-27"}},{"id":4302136,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T01:16:38.000Z","date":"2016-10-27","kind":"grant","acquired":true,"shares":7593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 27, 2016, David W. Anderson was granted 7,593 shares in lieu of fees for service as a director of the Company pursuant to a transaction exempt under Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. The reporting person's Form 4 filed on October 27, 2016 incorrectly reported the number of shares granted as 7,102 shares."}],"balance_after":16522,"source":{"system":"sec-edgar","filing":"0001161697-17-000270","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000270/form_4.xml","form_type":"4/A","original_submission_date":"2016-10-27"}},{"id":4305727,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-25T21:39:22.000Z","date":"2017-05-17","kind":"sale","acquired":false,"shares":23315,"price":0.4,"value":9326.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued to the Reporting Person in lieu of fees for service as a director of the Company pursuant to transactions exempt under Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended."}],"balance_after":6862,"source":{"system":"sec-edgar","filing":"0001161697-17-000263","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000263/form_4.xml","form_type":"4"}},{"id":4339400,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T21:38:03.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":7353,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30177,"source":{"system":"sec-edgar","filing":"0001161697-17-000222","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000222/form_4.xml","form_type":"4/A","original_submission_date":"2017-03-02"}},{"id":4339399,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-02T21:38:03.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":6793,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22824,"source":{"system":"sec-edgar","filing":"0001161697-17-000222","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000222/form_4.xml","form_type":"4/A","original_submission_date":"2017-03-02"}},{"id":4412198,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-02T21:21:13.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":6793,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22824,"source":{"system":"sec-edgar","filing":"0001161697-17-000139","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169717000139/form_4.xml","form_type":"4"}},{"id":4573743,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-27T21:57:28.000Z","date":"2016-10-27","kind":"grant","acquired":true,"shares":7102,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16031,"source":{"system":"sec-edgar","filing":"0001161697-16-001157","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169716001157/form_4.xml","form_type":"4"}},{"id":4591142,"issuer":{"id":6517,"kind":"organization","name":"KORU Medical Systems, Inc.","symbol":"KRMD"},"owners":[{"id":87875,"kind":"person","name":"Anderson David W","position":1,"cik":"0001304554","reported_name":"Anderson David W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-03T20:34:41.000Z","date":"2016-09-29","kind":"grant","acquired":true,"shares":8929,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8929,"source":{"system":"sec-edgar","filing":"0001161697-16-001097","document":"form_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704440/000116169716001097/form_4.xml","form_type":"4"}}]}